Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Endocrinology
Volume 2017, Article ID 2683120, 4 pages
https://doi.org/10.1155/2017/2683120
Case Report

Severe Thyrotoxicosis Secondary to Povidone-Iodine from Peritoneal Dialysis

Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada

Correspondence should be addressed to Kirstie Lithgow; ac.sha@woghtil.eitsrik

Received 14 June 2017; Accepted 27 July 2017; Published 24 August 2017

Academic Editor: Osamu Isozaki

Copyright © 2017 Kirstie Lithgow and Christopher Symonds. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Ezer, K. Caliskan, A. Parlakgumus, S. Belli, I. Kozanoglu, and S. Yildirim, “Preoperative therapeutic plasma exchange in patients with thyrotoxicosis,” Journal of Clinical Apheresis, vol. 24, no. 3, pp. 111–114, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. E. Roti and E. D. Uberti, “Iodine excess and hyperthyroidism,” Thyroid, vol. 11, no. 5, pp. 493–500, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. L. E. Braverman, R. D. Utiger, and A. P. Farwell, “The thyroid,” in A Fundamental and Clinical Text, Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 9th edition, 2005, Utiger RD Farwell AP. The Thyroid. A Fundamental and Clinical Text. Ninth edition. Lippincott Williams Wilkins. View at Google Scholar
  4. A. M. Leung and L. E. Braverman, “Consequences of excess iodine,” Nature Reviews Endocrinology, vol. 10, no. 3, pp. 136–142, 2014. View at Publisher · View at Google Scholar
  5. D. F. Gardner, D. R. Mars, R. G. Thomas, C. Bumrungsup, and R. I. Misbin, “Iodine retention and thyroid dysfunction in patients on hemodialysis and continuous ambulatory peritoneal dialysis,” American Journal of Kidney Diseases, vol. 7, no. 6, pp. 471–476, 1986. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Pramyothin, A. M. Leung, E. N. Pearce, A. O. Malabanan, and L. E. Braverman, “Clinical problem-solving: a hidden solution,” The New England Journal of Medicine, vol. 365, no. 22, pp. 2123–2127, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. E. N. Pearce, A. P. Farwell, and L. E. Braverman, “Thyroiditis,” The New England Journal of Medicine, vol. 348, no. 26, pp. 2646–2655, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Kawai, H. Tamai, T. Mori et al., “Thyroid histology of hyperthyroid Graves’ disease with undetectable thyrotropin receptor antibodies,” Journal of Clinical Endocrinology and Metabolism, vol. 77, no. 3, pp. 716–719, 1993. View at Publisher · View at Google Scholar · View at Scopus
  9. J. C. Lo, G. M. Chertow, A. S. Go, and C.-Y. Hsu, “Increased prevalence of subclinical and clinical hypothyroidism in persons with chronic kidney disease,” Kidney International, vol. 67, no. 3, pp. 1047–1052, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. C. M. Rhee, V. A. Ravel, E. Streja et al., “Thyroid functional disease and mortality in a national peritoneal dialysis cohort,” Journal of Clinical Endocrinology and Metabolism, vol. 101, no. 11, pp. 4054–4061, 2016. View at Publisher · View at Google Scholar · View at Scopus
  11. C. M. Rhee, G. A. Brent, C. P. Kovesdy et al., “Thyroid functional disease: an under-recognized cardiovascular risk factor in kidney disease patients,” Nephrology Dialysis Transplantation, vol. 30, no. 5, pp. 724–737, 2015. View at Publisher · View at Google Scholar
  12. E. M. Kaptein, “Thyroid hormone metabolism and thyroid diseases in chronic renal failure,” Endocrine Reviews, vol. 17, no. 1, pp. 45–63, 1996. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Brough and C. Jones, “Iatrogenic iodine as a cause of hypothyroidism in infants with end-stage renal failure,” Pediatric Nephrology, vol. 21, no. 3, pp. 400–402, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Piga, A. Serra, F. Boi, M. L. Tanda, E. Martino, and S. Mariotti, “Amiodarone-induced thyrotoxicosis: a review,” Minerva Endocrinologica, vol. 33, no. 3, pp. 213–228, 2008. View at Google Scholar · View at Scopus
  15. J. Gough and I. R. Gough, “Total thyroidectomy for amiodarone-associated thyrotoxicosis in patients with severe cardiac disease,” World Journal of Surgery, vol. 30, no. 11, pp. 1957–1961, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. A. J. O'Sullivan, M. Lewis, and T. Diamond, “Amiodarone-induced thyrotoxicosis: left ventricular dysfunction is associated with increased mortality,” European Journal of Endocrinology, vol. 154, no. 4, pp. 533–536, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. F. Bogazzi, L. Bartalena, and E. Martino, “Approach to the patient with amiodarone-induced thyrotoxicosis,” Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 6, pp. 2529–2535, 2010. View at Publisher · View at Google Scholar · View at Scopus